Understanding how mechanical forces affect PD-1 in cancer treatment
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
This study is looking at how physical forces affect a protein called PD-1, which is important for T cells that help fight cancer, and it aims to find new ways to improve cancer treatments by using special tools and mouse models.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10868437 on NIH RePORTER |
What this research studies
This research investigates the role of mechanical forces on the PD-1 protein, which is crucial for T cell function and often leads to T cell exhaustion in cancer. By using advanced physical science tools and mouse models of melanoma, the team aims to explore how these forces influence PD-1 interactions and signaling pathways. The study combines techniques such as mechanical tension probes and molecular dynamics simulations to gain insights into PD-1's behavior under different conditions. This innovative approach could lead to new strategies for enhancing cancer immunotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with melanoma or other cancers that may benefit from enhanced immunotherapy approaches.
Not a fit: Patients with non-cancerous conditions or those not eligible for immunotherapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve cancer immunotherapy by providing new ways to enhance T cell responses against tumors.
How similar studies have performed: While PD-1 blockade has been successful in cancer treatment, the specific mechanobiology approach being explored in this research is novel and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Zhu, Cheng — Georgia Institute of Technology
- Study coordinator: Zhu, Cheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.